NASDAQ: TCBP - TC Biopharm (Holdings) Plc

Yield per half year: -21.81%
Dividend yield: 0.00%
Sector: Healthcare

Share chart TC Biopharm (Holdings) Plc

Extended chart Simple chart
Financial Markets by TradingView

About TC Biopharm (Holdings) Plc

TC Biopharm (Holdings) Plc, биофармацевтическая компания клинической стадии, специализируется на разработке продуктов иммунотерапии на основе своей аллогенной платформы гамма-дельта Т-клеток. Линейка продуктов компании включает OmnImmune, аллогенный немодифицированный продукт для терапии гамма-дельта Т-клетками, используемый при лечении острого миелолейкоза; и ImmuniStim, немодифицированная клеточная терапия для лечения COVID-19. Компания была основана в 2013 году, ее штаб-квартира находится в Мазервелле, Великобритания.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2022-02-11
ISIN US87807D1037
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета gbp
Сайт https://tcbiopharm.com
Цена ао 6.61
Change price per day: 0% (0.71)
Change price per week: +7.58% (0.66)
Change price per month: +18.33% (0.6)
Change price per 3 month: -86.8% (5.38)
Change price per half year: -21.81% (0.908)
Change price per year: -77.6% (3.17)
Change price per 3 year: 0% (0.71)
Change price per 5 year: 0% (0.71)
Change price per 10 year: 0% (0.71)
Change price per year to date: +11.69% (0.6357)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0.2639 10
P/E 0 0
EV/EBITDA -0.0027 0
Total: 3.75

Efficiency

Title Value Grade
ROA, % -84.31 0
ROE, % -280.43 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.1038 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 12.19 2
Yield Ebitda, % 138.17 10
Yield EPS, % 1294.7 10
Total: 5
More

Institutions Volume Share, %
Armistice Capital, LLC 29750 4.4
Csenge Advisory Group 2600 0.38
Cresset Asset Management, LLC 2500 0.37
Modera Wealth Management, LLC 1624 0.24
XTX Topco Ltd 1362 0.2
Citadel Advisors Llc 1354 0.2
TWO SIGMA SECURITIES, LLC 1340 0.2
Renaissance Technologies, LLC 1100 0.16
Steward Financial Group LLC 200 0.03
Clear Street LLC 132 0.02



Head Job title Payment Year of birth
Mr. Christopher Camarra Executive Vice President of Communications N/A
Dr. Lauren Bor Ph.D. Head of Commercial Development Division N/A
Mr. Bryan Leland Kobel CEO & Director 1979 (46 years)
Mr. Martin Edward Thorp CFO & Director 1952 (73 years)

Address: United Kingdom, Motherwell, Maxim 1 - open in Google maps, open in Yandex maps
Website: https://tcbiopharm.com